The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer.
Cell Rep
; 41(13): 111878, 2022 12 27.
Article
in En
| MEDLINE
| ID: mdl-36577366
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell Rep
Year:
2022
Document type:
Article
Affiliation country:
Corea del Sur
Country of publication:
Estados Unidos